Edition:
United Kingdom

Smith & Nephew PLC (SN.L)

SN.L on London Stock Exchange

1,265.00GBp
23 Feb 2018
Change (% chg)

-5.00 (-0.39%)
Prev Close
1,270.00
Open
1,269.00
Day's High
1,269.50
Day's Low
1,258.50
Volume
1,554,066
Avg. Vol
3,242,085
52-wk High
1,442.00
52-wk Low
1,173.00

Select another date:

Thu, Feb 8 2018

Smith & Nephew meets lower end of guidance range for 2017

LONDON, Feb 8 Artificial hip and knee maker Smith & Nephew scraped into the bottom of its guidance range for 2017, with a 3 percent rise in revenue to $4.77 billion pounds and a 20 basis point increase in its trading margin, resulting in profit of $1.05 billion.

BRIEF-Smith & Nephew Sees Corporate Tax Rate On Trading Results In 20-21 Pct Range From 2018

* ‍AS RESULT OF US TAX CHANGE, FROM 2018 NOW EXPECTS A CORPORATE TAX RATE ON TRADING RESULTS IN RANGE 20% TO 21% FOR MEDIUM TERM​

BRIEF-Smith & Nephew announces acquisition of Rotation Medical Inc​

* ‍ACQUISITION COST IS $125 MILLION AND UP TO A FURTHER $85 MILLION OVER NEXT FIVE YEARS, CONTINGENT ON FINANCIAL PERFORMANCE​ Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Under pressure Smith & Nephew to focus on efficiency

LONDON Smith & Nephew said no major surgery is required for the artificial knee and hip maker to deliver shareholder value, even as it reported lacklustre sales that increase pressure on the company reportedly being stalked by activist investor Elliott.

UPDATE 2-Under pressure Smith & Nephew to focus on efficiency

* Says full-year growth will be at lower end of 3-4 pct guidance

BRIEF-S&N CEO will not confim if activist investor Elliott has stake

* Ceo says cost savings plan will be finalised by year-end results in feb

Smith & Nephew sees full-year growth at lower end of guidance

LONDON, Nov 3 European hip and knee maker Smith & Nephew said on Friday its growth for the year would be at the lower end of its guidance after reporting a 3 percent rise in revenue for the third quarter, just missing average market expectations.

Smith & Nephew to buy Rotation Medical for up to $210 million

LONDON Medical technology group Smith & Nephew , which some investors believe should streamline operations to make itself a more attractive takeover target, said on Monday it was buying a U.S. sports injury business for up to $210 million (£159 million).

UPDATE 1-Smith & Nephew to buy Rotation Medical for up to $210 mln

LONDON, Oct 23 Medical technology group Smith & Nephew, which some investors believe should streamline operations to make itself a more attractive takeover target, said on Monday it was buying a U.S. sports injury business for up to $210 million.

Smith & Nephew to buy Rotation Medical for up to $210 mln

LONDON, Oct 23 Medical technology group Smith & Nephew, which has been urged by activist investor Elliott Management to shed some operations according to media reports, has agreed to buy a U.S. tissue repair business for up to $210 million.

Select another date: